Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic markers linked to wool quality in Rambouillet sheep were identified, which can guide better breeding choices.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Preoperative pain assessment, regional anesthesia, and vitamin C can help prevent CRPS after surgery.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Mutations in the PTPRQ gene cause significant balance issues in mice due to hair bundle defects in the inner ear.

The circadian clock affects skin stem cell behavior, impacting aging and cancer risk.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Meis2 is essential for touch sensation and nerve function in mice.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hair oils can worsen seborrheic dermatitis in black patients.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Early diagnosis and treatment of TPP can prevent complications.

Modified stem cells that overexpress a specific protein can improve hair growth and reduce hair abnormalities in mice.